|
| Exchange Disseminated Time 11/02/2016 10:40:59 | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 11, 2016, have considered and approved the following:
1. Adoption of "Uniform Listing Agreement" as required to be entered by listed entity as per Regulation 109 of SEBI (Issue of Capital and Disclosure Requirements) Regulation, 2009 read with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 with the Stock Exchange. (Ref. SEBI Circular dated October 13, 2015.)
2. Policy for determining materiality of events as required under Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. |
|
|